Hydroxychloroquine with zinc could increase survival rates from COVID-19 by as much as 200%

0

A malaria drug touted by Donald Trump as a possible prevention for COVID-19 could increase the survival rates of severe patients by as much as 200 percent, according to a new study.

Scientists found that when ventilated patients with severe version of COVID were given high doses of hydroxychloroquine with zinc, their survival rate could increase dramatically.

Trump said in March 2020 that he was using it to avoid catching the virus, rather than treating it. He only became infected in October and was not treated with the drug.

Still, Trump’s allies on Wednesday highlighted the study, conducted by Saint Barnabas Medical Center in New Jersey on 255 patients.

It was published on May 31 on the medical site medRxiv.

A new study, published on the medical site medRxiv on May 31, suggests critically ill patients on a ventilator could be helped in their COVID-19 battle by high-dose hydroxychloroquine (above) and zinc — as promoted by Donald Trump

Trump’s spokesperson, Jason Miller, tweeted, “Oh.”

He quoted: ‘Study shows hydroxychloroquine and zinc treatments increased coronavirus survival nearly three times’

His son, Donald Trump Jr, said: “In the past week alone, we’ve learned that the media, the so-called fact-checkers and their Big Tech enforcers have lied to us about the lab leak theory, Hydroxychloroquine, and the Lafayette cleanup. Square.

All to hurt Donald Trump.

“What else are they lying about?”

Marjorie Taylor Greene, the fiercely pro-Trump congresswoman for Georgia, tweeted, “How many people died because Dr. Fauci said we trust science and hydroxychloroquine is not effective?

New Study Shows: Higher Dose Hydroxychloroquine + Azithromycin Therapy Improved Survival Nearly 200% in ventilated COVID patients.

“Trump was right.”

In April 2020, Trump stated, “We’ve bought a huge amount of hydroxychloroquine, which I think is a great malaria drug.

‘It has worked incredibly, it is a powerful drug against malaria. And there are signs that it works [coronavirus], some very strong signs.

‘And it has been around for a long time and is also very effective in lupus. So there are some very strong, powerful signs, and we’ll have to see.

“Because again, it’s being tested now, this is something new that just happened to us, the invisible enemy, we call it.”

He continued: ‘It’s a very strong, powerful drug, but it doesn’t kill people. We have some very good results and some very good tests. You have seen the same test I have.

“In France they had a very good test. But we don’t have time to say, gosh, let’s take a few years to test it out. And let’s start testing with the test tubes and the labs.

‘We don’t have time. I’d be happy to do that.’

A month later, on May 28, 2020, during a roundtable at the White House, he said, “I happen to be taking it.

“A lot of good things have come out of it. You would be amazed at how many people are using it, especially the frontline workers. Before you take it. The frontline workers, many, many are taking it.’

He added: ‘I take it, hydroxychloroquine. Right now, yes. I started it a few weeks ago. Because I think it’s good, I’ve heard a lot of good stories.’

The White House physician, Dr. Sean Conley, released a memo that evening, stating that after discussing the evidence for and against hydroxychloroquine with Trump, they concluded that “the potential benefit of the treatment outweighed the relative risks.”

Trump’s support for the unproven drug has been described by critics as reckless and dangerous.

Donald Trump, pictured on May 18, 2020. He had stated that he was taking hydroxychloroquine to prevent COVID infection

Donald Trump, pictured on May 18, 2020. He had stated that he was taking hydroxychloroquine to prevent COVID infection

On August 22, Trump continued to tout the benefits of hydroxychloroquine.  He would contract the virus two months later and be taken to hospital with serious symptoms symptomen

On August 22, Trump continued to tout the benefits of hydroxychloroquine. He would contract the virus two months later and be taken to hospital with serious symptoms symptomen

Last summer, Twitter restricted Trump Jr.’s account after he posted a video of doctors praising the drug’s effectiveness. The social media platform accused him of “spreading misleading and potentially harmful misinformation” regarding the coronavirus.

In March this year, the World Health Organization warned against using the drug to prevent the coronavirus, citing data suggesting it was ineffective.

But the authors of the new report state: ‘We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate that was 2.9 times higher than the other patients.

‘By using causal analysis and taking into account the weight-adjusted cumulative dose, we prove that the combined therapy, >3g HCQ and >1g AZM significantly increases survival of Covid patients on IMV and that the cumulative dose of HCQ > 80 mg/kg works significantly better. ‘

Hydroxychloroquine is still an unproven drug for the treatment of COVID.

Trump is seen on February 28.  His supporters have seized reports showing encouraging signs about hydroxychloroquine

Trump is seen on February 28. His supporters have seized reports showing encouraging signs about hydroxychloroquine

Early in the pandemic, Dr. Anthony Fauci, the nation’s leading public health expert, expressed interest in the drug, but he insisted more data was needed to prove its efficacy.

Fauci’s emailed comments about hydroxychloroquine are consistent with what he said publicly and the scientific consensus on the drug.

However, Republican critics accuse him of secretly backing the drug – although there is no evidence to prove it.

Several other studies in recent months, following Fauci’s email, have shown that hydroxychloroquine may be effective in certain situations.

A December study from the International Journal of Antimicrobial Agents found 84 percent fewer hospitalizations in patients treated with the drug, and a January study conducted by Hackensack Meridian Health found encouraging results in patients with mild symptoms treated with the drug. were treated.

.